Safety and Pharmacokinetics of ODM-209

Clinical trial NCT03878823 · COMPLETED

Trial details

NCT number: NCT03878823
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Advanced Breast Cancer Castration-resistant Prostate Cancer Metastatic Breast Cancer

Start date: 2019-04-17
Primary completion: 2024-01-09
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.